
iStar Medical SA raises €40.1m
Earlybird and BNP Paribas Fortis Private Equity and existing shareholders including Capricorn Partners, Walloon Region Investment Fund (SRIW) and...

MS: Polpharma joins forces with Sandoz
Natalizumab, which is currently being marketed by Biogen, is a humanized monoclonal antibody against the cell adhesion molecule α4-integrin. It is a...

ImCheck Therapeutics SAS raises €48m
The €48m financing was co-led by Pfizer Ventures, the venture capital arm of Pfizer Inc., and Bpifrance, with the new investors Wellington Partners,...

Sherlock Bioscience and Mologic enter partnership
Mologic said it will invest a part of an expansion to its $4.9m grant from the Bill and Melinda-Gates Foundation to finance access to Sherlock's...

Update: BIO-Europe growing further
According to still official figures, EBD Group's partnering event in Hamburg, the vibrant centre of Life Science Nord's life science cluster, hit a...

New malaria lead kills 99.9% of pathogens
The researchers built on the fact, that Plasmodium is highly dependent on external supply and metabolisation of vitamin B 5 (pantothenamide). They...

EMA greenlights new medicines
With the three innovative medicines and four generics the number of recommended medicines raised to 47 in 2019. The Committee saw a positive...